Latest Research in Liver Disease Diagnosis and Treatment

38 research papers · 2026 median publication year

Top Research Topics in Liver Disease Diagnosis and Treatment

Highest-Cited Papers

  1. Dietary intake, metabolic control and growth in patients with organic acidemia and urea cycle disorders
  2. Lean MAFLD and MASLD represent an underrecognized high risk phenotype beyond body mass index
  3. Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization
  4. Liver Fibrosis and IRS1 rs2972146 Are Associated With Weight Loss Response After Metabolic Bariatric Surgery
  5. Exploring the Association of Sū’ Mizāj al-Kabid al-Bārid with the Clinical Profile of Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Observational Study
  6. Modelling the impact of physical activity on MASLD in Saudi Arabia
  7. Outcome of Targeted Therapy for Obstructive Sleep Apnea in Children with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  8. Real-world clinical use of large neutral amino acids in phenylketonuria: a nationwide survey from Turkey under reimbursement constraints
  9. Association of progesterone and prolactin with hepatic steatosis in premenopausal women: A prospective cross-sectional study
  10. Clinical outcomes associated with GLP-1 receptor agonist use in metabolic dysfunction–associated steatohepatitis
  11. Body mass index modifies the association between occupational noise exposure duration and ultrasound‑detected hepatic steatosis: A cross-sectional study among male factory workers
  12. Universal Newborn Screening for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in a Safety-Net Well-Baby Nursery: A Quality Improvement Initiative
  13. Keyora Antarctic Krill Oil EP-10: The Metabolic Substrate-Partitioning Matrix: From Adipose Overflow and Insulin Resistance to Phospholipid Omega-3 Dose Matching, Multi-Domain Response, and the Metabolic Syndrome Intervention Algorithm
  14. Key Hepatokines Linking MASLD and Type 2 Diabetes: From Pathophysiological Mechanisms to Therapeutic Modulation
  15. Impact of bariatric surgery on cardiovascular and cerebrovascular outcomes in metabolic dysfunction–associated steatotic liver disease: a nationwide analysis
  16. Effects of Body-Weight Changes on the Risk of New-Onset Diabetes in Individuals With Non-Diabetic Metabolic Dysfunction-Associated Steatotic Liver Disease
  17. Evaluation of sleep quality and obstructive sleep apnea in non-alcoholic fatty liver disease: a cross-sectional study
  18. Hepatic and metabolic changes during Ramadan diurnal intermittent fasting in adults with MASLD and elevated ALT: a prospective multicenter study
  19. Hepatic Steatosis and Cardiovascular Risk in Obesity: A 10‐Year Follow‐Up Study From Childhood Into Young Adulthood
  20. Circulating Metabolites Associated with Prothrombin Time in Children with Congenital Heart Disease: An Untargeted Metabolomics Study
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
L3 Region - - 2026 Sep Q3

Liver Disease Diagnosis and Treatment

38 papers

Top Topics (10)

Liver Disease Diagnosis and Treatment22
Metabolism and Genetic Disorders2
Dietary Effects on Health2
Bariatric Surgery and Outcomes1
Obstructive Sleep Apnea Research1
Noise Effects and Management1
Neonatal Health and Biochemistry1
Diabetes, Cardiovascular Risks, and Lipoproteins1
Fibroblast Growth Factor Research1
Metabolomics and Mass Spectrometry Studies1

Top Publications (20)

1.Dietary intake, metabolic control and growth in patients with organic acidemia and urea cycle disorders2.Lean MAFLD and MASLD represent an underrecognized high risk phenotype beyond body mass index3.Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization4.Liver Fibrosis and IRS1 rs2972146 Are Associated With Weight Loss Response After Metabolic Bariatric Surgery5.Exploring the Association of Sū’ Mizāj al-Kabid al-Bārid with the Clinical Profile of Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Observational Study6.Modelling the impact of physical activity on MASLD in Saudi Arabia7.Outcome of Targeted Therapy for Obstructive Sleep Apnea in Children with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)8.Real-world clinical use of large neutral amino acids in phenylketonuria: a nationwide survey from Turkey under reimbursement constraints9.Association of progesterone and prolactin with hepatic steatosis in premenopausal women: A prospective cross-sectional study10.Clinical outcomes associated with GLP-1 receptor agonist use in metabolic dysfunction–associated steatohepatitis11.Body mass index modifies the association between occupational noise exposure duration and ultrasound‑detected hepatic steatosis: A cross-sectional study among male factory workers12.Universal Newborn Screening for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in a Safety-Net Well-Baby Nursery: A Quality Improvement Initiative13.Keyora Antarctic Krill Oil EP-10: The Metabolic Substrate-Partitioning Matrix: From Adipose Overflow and Insulin Resistance to Phospholipid Omega-3 Dose Matching, Multi-Domain Response, and the Metabolic Syndrome Intervention Algorithm14.Key Hepatokines Linking MASLD and Type 2 Diabetes: From Pathophysiological Mechanisms to Therapeutic Modulation15.Impact of bariatric surgery on cardiovascular and cerebrovascular outcomes in metabolic dysfunction–associated steatotic liver disease: a nationwide analysis16.Effects of Body-Weight Changes on the Risk of New-Onset Diabetes in Individuals With Non-Diabetic Metabolic Dysfunction-Associated Steatotic Liver Disease17.Evaluation of sleep quality and obstructive sleep apnea in non-alcoholic fatty liver disease: a cross-sectional study18.Hepatic and metabolic changes during Ramadan diurnal intermittent fasting in adults with MASLD and elevated ALT: a prospective multicenter study19.Hepatic Steatosis and Cardiovascular Risk in Obesity: A 10‐Year Follow‐Up Study From Childhood Into Young Adulthood20.Circulating Metabolites Associated with Prothrombin Time in Children with Congenital Heart Disease: An Untargeted Metabolomics Study
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.